We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
Peptides shop · Fibrinogen Binding Inhibitor Peptide · Reference sheet

Fibrinogen Binding Inhibitor Peptide

Reference sheet · Cell Adhesion · CPC catalog code RGDP-006

Identity

Name
Fibrinogen Binding Inhibitor Peptide
Catalog code
RGDP-006
Category
Cell Adhesion

Physicochemical properties

Sequence
H-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val-OH (trifluoroacetate salt)

Handling, storage & reconstitution

Upstream storage
CONDITIONS:**-20 ± 5 °C

General guidance for this class

Reference standards in the Cell Adhesion class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.

Mechanism & research applications

Fibrinogen Binding Inhibitor Peptide sits within the Cell Adhesion research class (CPC reference RGDP-006). Cell-adhesion peptides present short recognition motifs (RGD, YIGSR, IKVAV, and related sequences) that engage integrins and matrix receptors, allowing controlled studies of attachment, spreading, migration, and outside-in signaling. Investigators typically incorporate Fibrinogen Binding Inhibitor Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.

Studied for

  • Integrin engagement and blocking studies
  • Migration and wound-closure assays
  • Biomaterial and scaffold functionalization
  • Cancer cell adhesion and metastasis models

Frequently asked

What is Fibrinogen Binding Inhibitor Peptide?

Fibrinogen Binding Inhibitor Peptide (CPC catalog code RGDP-006) is a synthetic cell adhesion / ecm peptide in the cell adhesion category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.

What is Fibrinogen Binding Inhibitor Peptide studied for?

Published and internal research programs use Fibrinogen Binding Inhibitor Peptide as a reference standard in cell adhesion workflows — for example, integrin engagement and blocking studies and migration and wound-closure assays. Human clinical evidence is not established.

Is Fibrinogen Binding Inhibitor Peptide FDA-approved for human use?

No. Fibrinogen Binding Inhibitor Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.

How is Fibrinogen Binding Inhibitor Peptide typically used in the lab?

In a cell adhesion workflow, Fibrinogen Binding Inhibitor Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Typically used in coated-plate attachment assays, transwell migration, and SPR / BLI integrin-binding measurements.

Sources

View full product page →Back to catalog

Related peptides in Cell Adhesion

Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.

Integrin Binding Peptide
Cyclo (-RADfE), RGD negative control
Cyclo (-RADfK-), RGD negative control
RGD-targeted Proapoptotic Peptide
Cyclo (-RGDfK) Azido-PEG4
Cyclo (-GRGDSP)
Cyclo (-RGDfK)
Cyclo (-RGDyK)
Research use only. The peptides referenced on this page are supplied to qualified laboratories for in-vitro or non-human research. They are not drugs, foods, cosmetics, or dietary supplements, are not for human consumption, and are not intended to diagnose, treat, cure, or prevent any disease. Physicochemical values shown here are transcribed from the cited upstream reference sheet(s); confirm with your own certificate of analysis before use.
Ask Dot